Rubicon Organics reported disappointing Q1 2026 results. Earnings per share (EPS) came in at -0.04 CAD, significantly missing the forecast of 0.01 CAD. Revenue also fell short, reaching 13.69 million CAD against expectations of 14.22 million CAD.
Following the release, the stock plunged 11.11% in pre-market trading and declined another 4.55% in the latest session, closing at 0.44 CAD. The stock has fallen about 10% over the past week and roughly 7% year-to-date.
Revenue grew 11% year-over-year to 13.7 million CAD, despite a distribution strike in British Columbia and seasonal headwinds. The company maintains a current ratio of 2.54 and a debt-to-equity ratio of 0.26.
Management expects improved margins and revenue in the second half of 2026, driven by the ramp-up of the Cascadia facility and strategic initiatives. International expansion, including the launch of the 1964 brand in the UK, is also expected to contribute.
